These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31140861)

  • 1. The progresses in curcuminoids-based metal complexes: especially in cancer therapy.
    Zhang Y; Khan AR; Fu M; Zhai Y; Yu A; Zhai G
    Future Med Chem; 2019 May; 11(9):1035-1056. PubMed ID: 31140861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--part II.
    Kostova I
    Anticancer Agents Med Chem; 2010 Jun; 10(5):352-3. PubMed ID: 20545617
    [No Abstract]   [Full Text] [Related]  

  • 3. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
    Abid M; Shamsi F; Azam A
    Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diarylheptanoid: A privileged structure in drug discovery.
    Sun DJ; Zhu LJ; Zhao YQ; Zhen YQ; Zhang L; Lin CC; Chen LX
    Fitoterapia; 2020 Apr; 142():104490. PubMed ID: 32017968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry.
    Thota S
    Mini Rev Med Chem; 2016; 16(10):771. PubMed ID: 27161007
    [No Abstract]   [Full Text] [Related]  

  • 6. Preface.
    Prudhomme M
    Anticancer Agents Med Chem; 2017; 17(1):3. PubMed ID: 28143384
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview.
    Prudhomme M
    Anticancer Agents Med Chem; 2017; 17(1):2. PubMed ID: 28143383
    [No Abstract]   [Full Text] [Related]  

  • 8. Metal Complexes in Cancer Treatment: Journey So Far.
    Kumar Singh A; Kumar A; Singh H; Sonawane P; Pathak P; Grishina M; Pal Yadav J; Verma A; Kumar P
    Chem Biodivers; 2023 Apr; 20(4):e202300061. PubMed ID: 36824028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent researches in metal supramolecular complexes as anticancer agents.
    Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
    Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
    Zhang Z; Wang H; Yan M; Wang H; Zhang C
    Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diarylheptanoids with inhibitory effects on melanogenesis from the rhizomes of Curcuma comosa in B16 melanoma cells.
    Matsumoto T; Nakamura S; Nakashima S; Yoshikawa M; Fujimoto K; Ohta T; Morita A; Yasui R; Kashiwazaki E; Matsuda H
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5178-81. PubMed ID: 23910596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Arene Ruthenium Antitumor Complexes.
    Su W; Tang Z; Li P
    Mini Rev Med Chem; 2016; 16(10):787-95. PubMed ID: 27161008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progresses in TCM metal-based antitumour agents.
    Chen ZF; Liang H
    Anticancer Agents Med Chem; 2010 Jun; 10(5):412-23. PubMed ID: 20545619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcuminoids from
    Cunha Neto F; Marton LT; de Marqui SV; Lima TA; Barbalho SM
    Crit Rev Food Sci Nutr; 2019; 59(13):2136-2143. PubMed ID: 29565637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Next Generation of Anticancer Metallopharmaceuticals: Cancer Stem Cell-Active Inorganics.
    Laws K; Suntharalingam K
    Chembiochem; 2018 Nov; 19(21):2246-2253. PubMed ID: 30109911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.
    Morais TS; Valente A; Tomaz AI; Marques F; Garcia MH
    Future Med Chem; 2016 Apr; 8(5):527-44. PubMed ID: 27096164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.